GI side effects with oral semaglutide are reported at similar rates to injectable formulations, though some users report that nausea is more meal-dependent with the oral form
Fontana BD, Ziani PR, Canzian J, Mezzomo NJ, Mller TE, Dos Santos MM, et al
[3] Those with IPF have higher chances of getting lung cancer, at a rate of 13.5% where the most common cancer type is Squamous-cell carcinoma of the lung
For someone who has been consistent with semaglutide but has hit a plateau or hasnt achieved their desired weight loss goals, transitioning to tirzepatide could offer a new pathway to progress
Over 200 clinical trials have confirmed that GLP-1 receptor activation leads to measurable reductions in food intake and body weight
+ WeightMeds plans cover the cost of your doctor's visit, prescription medications, and free shipping, with no hidden or extra fees